Cytogenetics of bladder cancer

Cancer Genetics and Cytogenetics

Volumn 95, Issue 1, 1997, Pages 108-115

  Gibas, Zenon ^a   Gibas, Longina ^b  

^a St Mary Medical Center Langhorne   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CHROMOSOME 11; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CYTOGENETICS; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030932556     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00295-6     Document Type: Article

References (88)

1. Kroft SH, Oyasu R (1994): Urinary bladder cancer: Mechanisms of development and progression, Lab Invest 71:158-174.
2. Kakizoe T, Tobisu K. Takai K. Tanaka Y, Kishi K, Teshima S (1988): Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder. Cancer Res 48:2299-2303.
3. Sandberg AA (1986): Chromosome changes in bladder cancer: Clinical and other correlations. Cancer Genet Cytogenet 19:163-175.
4. Gibas Z, Prout G. Connolly JG, Pontes JE, Sandberg AA (1984): Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res 44:1257-1264.
5. Atkin NB, Baker MC (1985): Cytogenetic study of ten carcinomas of the bladder: Involvement of chromosomes 1 and 11. Cancer Genet Cytogenet 15:253-268.
6. Gibas Z, Prout GR, Pontes JE, Connolly JG, Sandberg AA (1986): A possible specific chromosome change in transitional cell carcinoma of the bladder. Cancer Genet Cytogenet 19:229-238.
7. Smeets W, Pauwels R, Laarakkers L. Debruyne F, Geraedts J (1987): Chromosomal analysis of bladder cancer. III. Nonrandom alterations. Cancer Genet Cytogenet 29:29-41.
8. Vanni R, Scarpa RM, Nieddu M, Usai E (1988): Cytogenetic investigation on 30 bladder carcinomas. Cancer Genet Cytogenet 30:35-42.
9. Mitelman F. (1994): Catalog of Chromosome Aberrations in Cancer. 5th Ed. New York, Wiley-Liss.
10. Babu VM, Lutz MD, Miles BJ. Farah RN, Weiss L, Van Dyke DL (1987): Tumor behaviour in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology, Cancer Res 47:6800-6805.
11. Powell I, Tyrkus M, Kleer E (1990): Apparent correlation of sex chromosome loss and disease course in urothelial cancer. Cancer Genet Cytogonet 50:97-101.
12. Presti JC, Reuter VE, Galan T, Fair WR, Cardon-Cardo C (1991): Molucular genetic: alterations in superficial and locally advanced human bladder cancer. Cancer Res 51: 5405-5409.
13. Hopman AHN, Poddighe PJ. Smeets AWGB, Moesker O, Beck JLM, Vooijs GP, Ramaekers FCS (1989): Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am J. Pathol 135:1105-1117.
14. Voorter C, Joos S. Bringuier PP, Vallinga M, Poddighe P, Schalken J, du Manoir S, Ramaekers F, Lichter P, Hopman A (1995): Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 146:1341-1354.
15. Kovacs G (1986): Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer, J Cancer Res Clin Oncol 110:249-251.
16. Berger CS, Sandberg AA, Todd IAD, Pennington RD, Haddad FS, Hecht BK, Hecht F (1986): Chromosome in kidney, ureter and bladder cancer. Cancer Genet Cytogenet 23:1-24.
17. Vanni R (1986): Letter to the editor. Cancer Res 46:4873.
18. Smeets W, Schapers R, Hopman A, Pauwels R, Ramaekers F (1993): Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer. Cancer Genet Cytogenet 71:97-99.
19. Bernues M, Casadevall C, Miro R, Caballin MR, Gelabert A, Egozcue J (1993): A case of transitional cell carcinoma of the bladder with a del(9) (q11q21.2). Cancer Genet Cytogenet 69:76-77.
20. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH (1991): Centromeric number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 51:3807-3813.
21. Hopman AHN, Moesker O, Smeets WGB, Pauwels RPE, Vooijs GP (1991): Numerical chromosome 1, 7, 9 and 11 aberrations in bladder cancer detected by in situ hybridization, Cancer Res 51:644-651.
22. Matsuyama H, Bergeheim USR, Nilsson I, Pan Y, Skoog L, Tribukait B, Ekman P (1994): Nonrandom numerical aberrations of chromosomes 7, 9 and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 77:118-124.
23. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM (1995): Chromosome 9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer 64:99-103.
24. Olumi AF, Tsai YC, Nichols PW, Skinner DG, Cain DR, Bender LI, Jones PA (1990): Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas. Cancer Res 50:7081-7083.
25. Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner DG, Jones PA (1990): Allelic losses of chromosome 9, 11 and 17 in human bladder cancer. Cancer Res 50:44-47.
26. Dalbagni G, Presti J, Reuter V, Fair WR, Cardon-Cardo C (1993): Genetic alterations in bladder cancer. Lancet 342: 469-471.
27. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote R, Dubeau L, Nichols PW, Hermann GC, Steven K. Horn T, Skinner DG, Jones PA (1994): Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784-799.
28. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cardon-Cardo C (1994): Chromosome 9 allelic losses and micro-satellite alterations in human bladder tumors. Cancer Res 54:2848-2851.
29. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG (1994): Allelotvpe of human bladder cancer. Cancer Res 54:531-538.
30. Cairns P, Shaw ME, Knowles MA (1993): Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res 53:1230-1232.
31. Ruppert JM, Tokino K. Sidransky D (1993): Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53:5093-5095.
32. Keen AJ, Knowles MA (1994): Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene 9:2083-2088.
33. Devlin J, Keen AJ, Knowles MA (1994): Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA. Oncogene 9:2757-2760.
34. Knowles MA (1995): Molecular genetics of bladder cancer. Br J Urol 75:57-66.
35. Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA (1995): p16(CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4:1569-1577.
36. Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach A, Cordon-Cardo C (1995): Deletion of the p16 and p15 genes in human bladder tumors, JNCI 87:1524-1529.
37. Southgate J, Proffitt J, Roberts P, Smith B, Selby P (1995): Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines. Br J Cancer 72:1214-1218.
38. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, Skolnick M, Cordon-Cardo C, Kamb A (1995): Genetic evidence in melanoma and bladder cancer that p16 and p53 function in two separate pathways of tumor suppression. Am J Pathol 146:1199-1206.
39. Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N (1995): Gensolin: A candidate tumor suppressor of human bladder cancer. Cancer Res 55:3328-3232.
40. Williamson M, Elder PA, Knowles MA (1994): The spectrum of TP53 mutations in bladder carcinoma, Genes Chromosom Cancer 9:108-118.
41. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994): Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
42. Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, Vogelstein B (1991): Identification of p53 mutations in bladder cancers and urine samples. Science 252:706-709.
43. Nemoto R, Nakamura I, Uchida K, Harada M (1995): Numerical chromosome aberrations in bladder cancer detected by in situ hybridization. Br J Urol 75:470-476.
44. DerKinderen DJ, Koten JW, Nagelkerke NJD, Tan KE, Beemr FA, Den Otter W (1988): Non-ocular cancer in patients with hereditary, retinoblastoma and their relatives. Int J Cancer 41:499-504.
45. Cairns P, Proctor AJ, Knowles MA (1991): Loss of heterozygosity at the Rb locus in frequent and correlates with muscle invasion in bladder cancer. Oncogene 6:2305-2309.
46. Xu HJ, Cairne P, Hu SX, Knowles MA, Benedict WF (1993): Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer 53:781-784.
47. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE (1992): Altered expression of the retinoblastoma gene product: Prognostic indicator in bladder cancer. JNCI 84:1251-1256.
48. Miyamoto H, Shuin T, Torigoe S, Iwasaki Y, Kubota Y (1995): Retinoblastoma gene mutations in primary human bladder cancer. Br J Cancer 71:831-835.
49. Vanni R, Peretti D, Scarpa RM, Usai E (1985): Derivative marker chromosome in bladder carcinoma. Cancer Genet Cytogenet 16:289-295.
50. Vanni R, Peretti D, Scarpa RM, Usai E (1987): Cytogenetics of bladder cancer: Rearrangements of the short arm of chromosome 11. Cancer Detect Prev 10:401-403.
51. Voorter CEM, Ummelen MIJ, Ramaekers FSC, Hopman AHN (1996): Loss of chromosome 11 and 11p/q imbalances in bladder cancer detected by fluorescence in situ hybridization. Int J Cancer 65:301-307.
52. Fearon ER, Feinberg AP, Hamilton SH, Vogelstein B (1985): Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature 318:377-380.
53. Shipman R, Schraml P, Colombi M, Raefle G, Ludwig CU (1993): Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma. Hum Genet 91:455-458.
54. Reznikoff CA, Kao C, Messing EM, Newton M, Swaminathan S (1993): A molecular genetic model of human bladder carcinogenesis. Sem Cancer Biol 4:143-152.
55. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvilli Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996): The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint is abnormal in digestive tract cancers. Cell 587-597.
56. Perucca D, Szepetowski P, Simon M-P, Gaudray P (1990): Molecular genetics of human bladder carcinomas. Cancer Genet Cytogenet 49:143-156.
57. Brewster SF, Gingell JC, Browne S, Brown KW (1994): Loss of heterozygosity on chromosome 18q is associated with muscle invasive transitional cell carcinoma of the bladder. Br J Cancer 70:697-700.
58. Kallionemi A, Kallionemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F (1995): Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosom Cancer 12:213-219.
59. Knowles MA, Shaw ME, Proctor AJ (1993): Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction length polymorphisms and microsatellite polymorphisms. Oncogene 8:1357-1364.
60. Elder PA, Bell SM, Knowles MA (1994): Deletion of two regions on chromosome 4 in bladder carcinoma: Definition of a critical 750kb region at 4p16.3. Oncogene 9:3433-3436.
61. Babu VR, Miles BJ, Cerney JC, Weiss L, van Dyke DL (1989): Chromosome 21q22 deletion. A specific chromosome change in a new bladder cancer subgroup. Cancer Genet Cytogenet 38:127-129.
62. Chang WY-H, Cairns P. Schoenberg MP, Polascik TJ, Sidransky D (1995): Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res 55:3246-3249.
63. Atkin NB, Baker MC (1991): Numerical chromosome changes in 165 malignant tumors. Evidence of a nonrandom distribution of normal chromosomes. Cancer Genet Cytogenet 52: 113-121.
64. Wang M-R, Perissel B, Taillandier J, Kemeny J-L, Fonck Y, Lautier A, Benkhalifa M, Malet P (1994): Nonrandom changes of chromosome 10 in bladder cancer. Detection by FISH to interphase nuclei. Cancer Genet Cytogenet 73:8-10.
65. Matsuyama H, Bergerheim USR, Nilsson I, Pan Y, Skoog L, Tribukait B, Ekman P (1994): Nonrandom numerical aberrations of chromosomes 7, 9 and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 77:118-124.
66. Atkin NB, Fox MF (1990): 5q deletion. The sole chromosomal change in a carcinoma of the bladder. Cancer Genet Cytogenet 46:129-131.
67. Berrozpe G, Miro R, Caballin MR, Salvador J, Egozcue J (1990): Trisomy 7 may be a primary change in noninvasive transitional cell carcinoma of the bladder. Cancer Genet Cytogenet 50:9-14.
68. Sandberg AA, Berger CS, Haddad FS, Kerr D, Hecht F (1986): Chromosome change in transitional cell carcinoma of the ureter. Cancer Genet Cytogenet 19:335-340.
69. Gibas Z, Griffin CA, Emanuel BS (1987): Trisomy 7 and i(5p) in a transitional cell carcinoma of the ureter. Cancer Genet Cytogenet 25:369.
70. Vanni R, Nieddu M, Scarpa RM, Migliari R, Usai E (1989): Trisomy 7 in a case of transitional cell carcinoma of the kidney. Cancer Genet Cytogenet 41:149-151.
71. Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Andren-Sandberg A, Hagerstrand I, Mitelman F (1991): Trisomy 7 in short-term cultures of colorectal adenocarcinomas. Genes Chrom Cancer 3:149-152.
72. Lee JAS, Pathak S, Hopwood V, Tomasovic B, Mullis TD, Baker FL, Spitzer G, Neihart JA (1987): Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue. Cancer res 47:6349-6352.
73. Elfvig P, Cigudosa JC, Lundgren R, Limon J, Mandahl N. Kristoffersson U, Heim S, Mitelman F (1990): Trisomy 7, trisomy 10 and loss of the Y chromosome in short-term cultures of normal kidney tissue. Cancer Genet Cytogenet 53:123-125.
74. Heim S, Mandahl N, Jin Y, Stromblad S, Lindstrom E, Salford LG, Mitelman F (1989): Trisomy 7 and sex chromosome loss in human brain tissue. Cancer Genet Cytogenet 52:136-138.
75. Dal Cin P, Aly MS, Delabie J, Ceuppens JL, Van Gool S, Van Danune B, Baert L, Van Poppel H, Van den Berghe H (1992): Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue. PNAS 89:9744-9748.
76. Atkin NB (1986): Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet 21:279-285.
77. Tyrkus M, Powell I, Fakr W (1992): Cytogenetic studies of carcinoma in situ of the bladder: Prognostic implications. J Urol 148:44-46.
78. Poddighe PJ, Ramaekers FCS, Smeets AWGB, Voojis GP, Hopman AHN (1992): Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: Interphase cytogenetics combining a centromeric, telomeric, and library DNA probe. Cancer Res 52:4929-4934.
79. Paraskeva C, Harvey A, Finerty S. Powell SC (1989): Possible involvement of chromosome 1 in in vitro immortalization: evidence from progression of a human adenoma-derived cell line in vitro. Int J Cancer 43:743-746.
80. Sandberg AA (1992): Chromosome changes in early bladder neoplasms. J Cell Biochem (Suppl) 161:76-79.
81. Sandberg AA, Berger CS (1994): Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 151:545-560.
82. Sauter G, Moch H, Wagner U, Novotna H, Gasser TC, Mattarelli G, Mihatsch MJ, Waldman FM (1995): Y chromosome loss detected by FISH in bladder cancer. Cancer Genet Cytogenet 82:163-169.
83. Betz J, Meloni A, Sandberg AA (1996): FISH studies of the Y chromosome in male urinary cells. Cancer Genet Cytogenet 88:155-157.
84. Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschmann R, Narayan P, Mihatsch MJ, Waldman FM (1995): c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol 146:1131-1139.
85. Coombs LM, Pigott DA, Sweeney, Proctor AJ, Eydmann ME, Parkinson C, Knowles MA (1991): Amplification and overexpression of c-erBB2 in transitional cell carcinoma of the urinary bladder. Br J Cancer 63:601-608.
86. Sauter G, Moch D, Carroll P, Kerschmann R, Chew K, Mihatsch MJ, Gudat F. Waldman F (1993): Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 53:2199-2203.
87. Ye DW, Zheng JF, Qian SX, Ma YJ (1993): Correlation between the expression of oncogenes ras and c-erbB2 and the biological behaviour of bladder tumors. Urol Res 21:39-43.
88. Meloni AM, Peier AM, Haddad FS, Powell IJ, Block AW, Huben RP, Todd I, Potter W, Sandberg AA (1993): A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings and tumors. Cancer Genet Cytogenet 71:105-118.